Vaxart, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OQX

30 Apr 2026

VXRT

10-K/A: Vaxart Files 10-K/A for FY 2025 Governance Disclosures

Vaxart, Inc. filed an amendment to its 2025 Annual Report to provide required Part III disclosures regarding directors, executive compensation, and corporate governance.

OQX

20 Mar 2025

VXRT

Vaxart, INC

10-K: Vaxart's 2024 10-K Filing: COVID-19 Program Faces Uncertainty Amidst Funding Changes

Vaxart's 2024 10-K filing reveals a year of progress in vaccine development, but also highlights significant uncertainties surrounding its COVID-19 program due to potential funding termination.

OQX

14 Mar 2024

VXRT

Vaxart, INC

10-K: Vaxart Outlines Common Stock Details and Regulatory Compliance in 10-K Filing

Vaxart's 10-K filing details the structure of its common stock, anti-takeover provisions, and compliance with securities regulations.